Reviewed by Michael Gill, B. Sc.
25 Nerve Pain Clinical Trials Near Me
Top Hospitals for Nerve Pain Clinical Trials
Image of Stanford University in California.
Stanford University
Stanford
4Active Trials
6All Time Trials for Nerve Pain
2016First Nerve Pain Trial
Image of Virginia Commonwealth University in Virginia.
Virginia Commonwealth University
Richmond
3Active Trials
5All Time Trials for Nerve Pain
2014First Nerve Pain Trial
Nerve Pain Clinical Trials by Phase of Trial
Phase < 1 Nerve Pain Clinical Trials
1Active Nerve Pain Clinical Trials
1Number of Unique Treatments
1Number of Active Locations
Coordinated Reset spinal cord stimulation
Nerve Pain Clinical Trials by Age Group
18+ Nerve Pain Clinical Trials
72Active Nerve Pain Clinical Trials
Paresthesia-Free StimulationPNS Therapy plus Conventional Medical ManagementTranscranial Magnetic Stimulation300 mg Gabapentin 3X per dayVenlafaxine 37.5 MGCoordinated Reset spinal cord stimulationMBSR treatmentQutenza (capsaicin) 8% topical system
Most Recent Nerve Pain Clinical Trials
Clinical Trial
Began Recruiting Date
Phase
Top Treatments for Nerve Pain Clinical Trials
Treatment Name
Active Nerve Pain Clinical Trials
All Time Trials for Nerve Pain
First Recorded Nerve Pain Trial
Active DBS
2
2
2017
Spinal Cord Stimulation
2
5
2014
[18F]FTC-146
2
2
2018
Paresthesia-Free Stimulation
1
1
2022
PNS Therapy plus Conventional Medical Management
1
1
2022
Recently Completed Studies with FDA Approved Treatments for Nerve Pain
Treatment
Year
Sponsor
LY3526318
2022
Eli Lilly and Company
ETX-018810
2020
Eliem Therapeutics (UK) Ltd.
Naloxone Hydrochloride 0.4 MG/ML
2020
Seema Capoor
BAY1817080
2020
Bayer
LY3016859
2020
Eli Lilly and Company
LX9211 high dose
2020
Lexicon Pharmaceuticals
NYX-2925 50 mg
2019
Aptinyx

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 2nd, 2021

Last Reviewed: November 2nd, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

References1 Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361-70. https://pubmed.ncbi.nlm.nih.gov/68808202 Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007 May;39(2):175-91. https://pubmed.ncbi.nlm.nih.gov/176953433 Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007 May;39(2):175-91. doi: 10.3758/bf03193146. https://pubmed.ncbi.nlm.nih.gov/176953434 Farrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole MR. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain. 2001 Nov;94(2):149-158. doi: 10.1016/S0304-3959(01)00349-9. https://pubmed.ncbi.nlm.nih.gov/116907285 O'Connell NE, Ferraro MC, Gibson W, Rice AS, Vase L, Coyle D, Eccleston C. Implanted spinal neuromodulation interventions for chronic pain in adults. Cochrane Database Syst Rev. 2021 Dec 2;12:CD013756. doi: 10.1002/14651858.CD013756.pub2. Review. https://pubmed.ncbi.nlm.nih.gov/348544736 Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia. 2018 Jan;38(1):1-211. doi: 10.1177/0333102417738202. https://pubmed.ncbi.nlm.nih.gov/293689497 Lefaucheur JP, André-Obadia N, Antal A, Ayache SS, Baeken C, Benninger DH, Cantello RM, Cincotta M, de Carvalho M, De Ridder D, Devanne H, Di Lazzaro V, Filipović SR, Hummel FC, Jääskeläinen SK, Kimiskidis VK, Koch G, Langguth B, Nyffeler T, Oliviero A, Padberg F, Poulet E, Rossi S, Rossini PM, Rothwell JC, Schönfeldt-Lecuona C, Siebner HR, Slotema CW, Stagg CJ, Valls-Sole J, Ziemann U, Paulus W, Garcia-Larrea L. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS). Clin Neurophysiol. 2014 Nov;125(11):2150-2206. doi: 10.1016/j.clinph.2014.05.021. Epub 2014 Jun 5. Review. https://pubmed.ncbi.nlm.nih.gov/250344728 Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, Jensen MP, Katz NP, Kerns RD, Stucki G, Allen RR, Bellamy N, Carr DB, Chandler J, Cowan P, Dionne R, Galer BS, Hertz S, Jadad AR, Kramer LD, Manning DC, Martin S, McCormick CG, McDermott MP, McGrath P, Quessy S, Rappaport BA, Robbins W, Robinson JP, Rothman M, Royal MA, Simon L, Stauffer JW, Stein W, Tollett J, Wernicke J, Witter J; IMMPACT. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain. 2005 Jan;113(1-2):9-19. Review. https://pubmed.ncbi.nlm.nih.gov/156213599 Ljungqvist O, Scott M, Fearon KC. Enhanced Recovery After Surgery: A Review. JAMA Surg. 2017 Mar 1;152(3):292-298. doi: 10.1001/jamasurg.2016.4952. Review. https://pubmed.ncbi.nlm.nih.gov/2809730510 Rolke R, Baron R, Maier C, Tölle TR, Treede -DR, Beyer A, Binder A, Birbaumer N, Birklein F, Bötefür IC, Braune S, Flor H, Huge V, Klug R, Landwehrmeyer GB, Magerl W, Maihöfner C, Rolko C, Schaub C, Scherens A, Sprenger T, Valet M, Wasserka B. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): standardized protocol and reference values. Pain. 2006 Aug;123(3):231-243. doi: 10.1016/j.pain.2006.01.041. Epub 2006 May 11. Erratum in: Pain. 2006 Nov;125(1-2):197. https://pubmed.ncbi.nlm.nih.gov/16697110